Results 121 to 130 of about 1,676 (161)

A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy Controls. [PDF]

Exp Dermatol
Baldi S, Bertorello S, Cei F, Nannini G, Menicatti M, Niccolai E, Bartolucci G, Baffa ME, Pipitò C, Antiga E, Amedei A, Maglie R.   +11 more
europepmc   +1 more source

The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study. [PDF]

Cancer Immunol Immunother
Saffuri N, Boyango I, Cohen I, Ali-Saleh Z, Dawood M, Khamaysi Z, Yogev D, Avitan-Hersh E.   +7 more
europepmc   +1 more source

Refractory linear IgA dermatosis in childhood: a successful response to rituximab. [PDF]

An Bras Dermatol
Wakisaka PS, Lima Rodrigues LMC, Miyamoto D, Maruta CW, Santi CG, Aoki V.   +5 more
europepmc   +1 more source

Case Report: Occupational bullous dermatosis: first report of skin lesions induced by PVC welding fume in a manufacturing worker. [PDF]

Front Immunol
Stufano A, Lovreglio P, Cazzato G, Danza P, Ravallese R, Cassano N, Vena GA, Ambrogio F, Tirone B, Foti C.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Role of BP230 autoantibodies in bullous pemphigoid

Journal of Dermatology, 2020
AbstractBullous pemphigoid (BP) is an autoimmune disease associated with subepidermal blistering due to autoantibodies directed against BP180 and BP230. BP180 is currently considered as the major pathogenic autoantigen. However, previous clinical findings suggested that anti‐BP230 autoantibodies alone can cause skin lesions in animal models and many BP
Yen-Chi Shih, Bo Wang, Huijie Yuan
exaly   +3 more sources

BP230 IgE autoantibodies in topical‐steroid‐resistant bullous pemphigoid

Journal of Dermatology, 2021
AbstractBackgroundIgE autoantibodies targeting BP230 can be identified in 38%–68% of bullous pemphigoid (BP) patients, yet the diagnostic and pathogenic value of anti‐BP230 IgE still remains inconclusive.ObjectiveWe intend to investigate the clinical and immunological characteristics of anti‐BP230 IgE in BP patients.Methods and ResultsFifty‐four BP ...
Yen-Chi Shih, Huijie Yuan, Jia Shen
exaly   +3 more sources

BP230- and BP180-specific Auto-Antibodies in Bullous Pemphigoid [PDF]

Journal of Investigative Dermatology, 2004
Bullous pemphigoid is a subepidermal blistering disease associated with auto-antibodies (auto-ab) to BP180 and BP230. We developed ELISAs utilizing baculovirus-encoded recombinant proteins of BP230 and BP180 and studied their diagnostic and prognostic values by assessing the profile of the auto-ab response in 127 patients with BP. 39 patients had focal
Sybille Thoma-Uszynski, Thomas Hunziker, Christos C Zouboulis   +2 more
exaly   +4 more sources

Evaluation of a New ELISA Assay for Detection of BP230 Autoantibodies in Bullous Pemphigoid

Annals of the New York Academy of Sciences, 2009
The diagnosis of bullous pemphigoid is based on clinical observations and on the presence of autoantibodies directed against proteins of the dermoepidermal junction. Human recombinant BP180 and BP230 peptides have been used to develop new quantitative enzyme immunoassays (EIA) for the detection of specific antibodies.
Marilina Tampoia, Raffaele Filotico, Antonietta FONTANA   +2 more
exaly   +3 more sources

Development of an ELISA for the detection of autoantibodies to BP230

Clinical Immunology, 2004
Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies against the transmembrane hemidesmosomal protein BP180/collagen type XVII and the intracellular plaque protein BP230. The aim of the present study was to develop an ELISA system for the detection of circulating autoantibodies to BP230.
Arno, Kromminga, Cassian, Sitaru, Christine, Hagel, Susanne, Herzog, Detlef, Zillikens   +4 more
openaire   +2 more sources

Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins

European Journal of Dermatology, 2016
To confirm that sera from some BP patients reactive exclusively to the BP230 and to study the clinical and immunological characteristics of this condition.BP patients were divided into three groups: BP reactive only to BP230 (BP230-BP), BP reactive to both BP180 and BP230 (BP180-BP230-BP) and BP reactive only to BP180 (BP180-BP), based on the results ...
Taihei, Hayakawa, Kwesi, Teye, Takahisa, Hachiya, Rie, Uehara, Masahiro, Hashiguchi, Tamihiro, Kawakami, Xiaoguang, Li, Atsunari, Tsuchisaka, Koji, Ohara, Ryosuke, Sogame, Hiroshi, Koga, Takahiro, Hamada, Chika, Ohata, Minao, Furumura, Norito, Ishii, Hideo, Fukano, Kazuo, Shimozato, Takashi, Hashimoto   +17 more
openaire   +2 more sources